Somatic Genetic Testing Market Overview, Size, Share and Forecast 2031

Comments · 199 Views

The Somatic Genetic Testing Market in 2023 is US$ 9.06 billion, and is expected to reach US$ 18.76 billion by 2031 at a CAGR of 9.5%.

The Somatic Genetic Testing Market in 2023 is US$ 9.06 billion, and is expected to reach US$ 18.76 billion by 2031 at a CAGR of 9.5%.

FutureWise Research published a report that analyzes Somatic Genetic Testing Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Somatic Genetic Testing research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Somatic Genetic Testing Market Sample

 

Somatic Genetic Testing Market Segmentation:

By Product Type

·          Products

·          Kits and Assays

·          Instruments

·          Software

·          Services

By Sample

·          Tissue-Based

·          Blood-Based

·          Bone Marrow Aspirates

·          Others

By Technology

·          Sequencing

·          Next-Generation Sequencing (NGS)

·          Sequencing by Synthesis

·          Other Next-Generation Sequencing Technologies

·          Traditional Sequencing

·          Polymerase Chain Reaction

·          Real-Time Polymerase Chain Reaction (RT-PCR)

·          Digital Polymerase Chain Reaction (dPCR)

·          Microarray

·          Other Technologies

By Application

·          Solid Tumors

·          Breast Cancer

·          Prostate Cancer

·          Colorectal Cancer

·          Lung Cancer

·          Liver Cancer

·          Ovarian Cancer

·          Other Solid Tumors

·          Hematological Malignancies

·          Leukemia

·          Lymphoma

·          Myeloma

By End User

·          Academic and Research Institutions

·          Hospitals and Diagnostic Laboratories

·          Pharmaceutical and Biotechnology Companies

·          Contract Research Organizations

·          Other

By Region

·          North America

·          Europe

·          Asia-Pacific

·          Latin America

·          Middle East and Africa

 

Key Market Players:

·          Agilent Technologies, Inc.

·          ARUP Laboratories

·          ASURAGEN Inc.

·          Beijing Genomics Institute (BGI) Genomics Co., Ltd

·          bioMerieux S.A.

·          CENTOGENE N.V.

·          CIRCULOGENE Theranostics, LLC

·          F. Hoffmann-La Roche Ltd.

·          Guardant Health, Inc.

·          Illumina, Inc.

·          Invivoscribe, Inc.

·          Laboratory Corporation of America Holdings

·          Mission Bio

·          NeoGenomics Laboratories, Inc.

·          OmniSeq

·          Oxford Nanopore Technologies Ltd.

·          Pacific Biosciences of California, Inc.

·          QIAGEN N.V.

·          Quest Diagnostics Incorporated

·          Thermo Fisher Scientific Inc.

 

Please visit full report of the Somatic Genetic Testing market @ Visit Somatic Genetic Testing Market

 

Competitive Landscape:

·         Tier one players - market players with a significant share of the market

·         Tier two players

·        

Comments